Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Oct 15 - Oct 20
Where they overlap and where they don't Complementary Mechanism Targets Target Origin BPC-157 Gastric juice protein fragment (15 amino acids) TB-500 Thymosin Beta-4 fragment (LKKTETQ region) Target Primary action BPC-157 Local tissue repair signaling TB-500 Systemic cell migration and mobilization Target Angiogenesis BPC-157 VEGF upregulation, NO pathway TB-500 Endothelial migration, VEGF crosstalk Target Cell migration BPC-157 Indirect, via growth factors TB-500 Direct (G-actin sequestering) Target Best-evidence tissue BPC-157 Tendon, gut, gastric mucosa (preclinical) TB-500 Cardiac, corneal, skin (preclinical + early human T4) Target Reported in vivo half-life BPC-157 ~4 hours (animal estimates) TB-500 ~23 days (animal estimates) Half-life figures are pharmacokinetic estimates from animal studies
This way, a medication can be reconstituted once and then used multiple times over a period of 28 days, the shelf-life of bacteriostatic water once the vial is opened
Malik, M., Webb, J
Each person's blood vessels sit at different depths and respond uniquely to needle trauma, which explains why some patients experience marked discoloration while others see none
These treatments can improve metabolic markers, reduce the risk of developing type 2 diabetes, lower cholesterol levels, and even positively impact cardiovascular health
